These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19404853)

  • 21. Fluorescence in situ hybridization analysis of atypical melanocytic proliferations and melanoma in young patients.
    DeMarchis EH; Swetter SM; Jennings CD; Kim J
    Pediatr Dermatol; 2014; 31(5):561-9. PubMed ID: 24924836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
    Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
    Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
    Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
    Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.
    Lai Y; Wu Y; Liu R; Lu A; Zhou L; Jia L; Diao X; Li Z
    Diagn Pathol; 2020 May; 15(1):51. PubMed ID: 32393283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.
    Gaiser T; Kutzner H; Palmedo G; Siegelin MD; Wiesner T; Bruckner T; Hartschuh W; Enk AH; Becker MR
    Mod Pathol; 2010 Mar; 23(3):413-9. PubMed ID: 20081813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
    Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P
    Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms.
    Reimann JDR; Salim S; Velazquez EF; Wang L; Williams KM; Flejter WL; Brooke L; Sunder S; Busam KJ
    Mod Pathol; 2018 Nov; 31(11):1733-1743. PubMed ID: 29955141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
    Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
    Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
    Gerami P; Jewell SS; Morrison LE; Blondin B; Schulz J; Ruffalo T; Matushek P; Legator M; Jacobson K; Dalton SR; Charzan S; Kolaitis NA; Guitart J; Lertsbarapa T; Boone S; LeBoit PE; Bastian BC
    Am J Surg Pathol; 2009 Aug; 33(8):1146-56. PubMed ID: 19561450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
    Mesbah Ardakani N; Thomas C; Robinson C; Mina K; Harvey NT; Amanuel B; Wood BA
    Pathology; 2017 Apr; 49(3):285-291. PubMed ID: 28274670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors.
    Ponti G; Ruini C; Massi D; Pellacani G; Tomasi A; Paglierani M; Loschi P; Seidenari S
    Melanoma Res; 2013 Dec; 23(6):474-80. PubMed ID: 24077512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.
    Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M
    Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.